Cell therapy weekly: Therapy utilizing fibroblasts against coronavirus receives patent
Also this week: Stem cell transplant removes active HIV from a patient, Lonza announces collaboration for point-of-care manufacturing and autologous immunotherapy, and Cellectis receives a patent for CRISPR–Cas9 edited CAR-T.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>